GPT and liver disorder: Therapeutic strategies for CHB include finite treatment with pegylated-interferon (PEG-IFN) and indefinite treatment with nucleos(t)ide analogues (NAs) [9]; the latter allows an effective suppression of viral replication, normalization of alanine aminotransferase (ALT) and thus the prevention of liver disease progression [10].